Tesamorelin

Description

Tesamorelin is a synthetic 44-amino-acid peptide research material structurally related to growth hormone-releasing hormone and containing a defined N-terminal trans-3-hexenoyl modification. It is produced through controlled peptide synthesis and used in laboratory settings for analytical, biochemical, and molecular investigations under defined experimental conditions. The material is commonly supplied in lyophilized form to support stability and integrity during appropriate laboratory storage and handling.

Research Applications:

Tesamorelin may be utilized in controlled laboratory research settings for applications such as:

• Analytical characterization of peptide identity, sequence, and structural modifications
• Investigation of peptide-receptor interactions in controlled biochemical and cell-based assay systems
• Evaluation of peptide stability, degradation, and physicochemical behavior under defined laboratory conditions
• Examination of structure-activity relationships involving modified GHRH-related peptide sequences

Storage and Handling:

• Store lyophilized material at -20°C or according to batch-specific supplier documentation.
• Protect the material from excessive moisture, heat, and prolonged light exposure.
• Once prepared in solution, follow validated stability data and the specific laboratory protocol for storage conditions.
• Avoid unnecessary repeated freeze-thaw cycles and use appropriate laboratory handling procedures to minimize contamination and degradation.

Product Specifications:

• Purity: Refer to batch-specific HPLC results or Certificate of Analysis
• Appearance: Typically supplied as a white to off-white lyophilized powder; verify against batch-specific documentation
• Solubility: Dependent on concentration, pH, formulation, and solvent system; refer to supplier-specific technical documentation

Compliance Notice:

Tesamorelin is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product is supplied exclusively for controlled laboratory, analytical, and in vitro research purposes and is not intended for diagnostic, therapeutic, or clinical applications. Misuse of this product is strictly prohibited and may violate applicable federal, state, or local laws. By purchasing this product, the buyer represents and warrants that it will be used solely for legitimate laboratory research purposes.

Technical Note: The molecular formula C₂₂₁H₃₆₆N₇₂O₆₇S and molecular weight of approximately 5135.9 g/mol correspond to the commonly referenced tesamorelin molecular structure. Tesamorelin is a 44-amino-acid modified GHRH analogue incorporating an N-terminal trans-3-hexenoyl group, so its molecular identity differs from the corresponding unmodified peptide sequence. Reported analytical values may vary depending on salt form, counterions, hydration state, or supplier-specific formulation. Final product-page specifications should therefore match the supplier documentation and the batch-specific Certificate of Analysis (COA).